Cargando…

Combinations of targeted therapies in human cancers

Detalles Bibliográficos
Autores principales:	Decaudin, Didier, Le Tourneau, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115885/ https://www.ncbi.nlm.nih.gov/pubmed/27783563 http://dx.doi.org/10.18632/aging.101085

Ejemplares similares

Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer
por: Borcoman, Edith, et al.
Publicado: (2020)

Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets
por: Saada-Bouzid, Esma, et al.
Publicado: (2019)

Special Issue: Resistance to Targeted Therapies in Human Cancer
por: Lee, Tae-Won, et al.
Publicado: (2023)

Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
por: Borcoman, Edith, et al.
Publicado: (2017)

Targeting in Cancer Therapies
por: Mangues, Ramon, et al.
Publicado: (2016)

Targeted cancer therapies
por: Yan, Li, et al.
Publicado: (2011)

Targeted therapies for cancer
por: Zhou, Zhijun, et al.
Publicado: (2022)

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
por: Stimmer, Lev, et al.
Publicado: (2014)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
por: Harris, Adrian L.
Publicado: (2019)

Cancer biomarkers for targeted therapy
por: Liu, Delong
Publicado: (2019)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Targeted therapy: tailoring cancer treatment
por: Yan, Min, et al.
Publicado: (2013)

Editorial Preface for Targeted Cancer Therapy
por: Chen, Guan, et al.
Publicado: (2018)

Inflammation as a Target in Cancer Therapy
por: Leon-Cabrera, Sonia, et al.
Publicado: (2019)

Targeting FTO for cancer therapy and more
por: Qing, Ying, et al.
Publicado: (2021)

Cancer Prevention with Molecular Targeted Therapies
por: Paleari, Laura
Publicado: (2022)

Targeted Radionuclide Therapy of Cancer and Infections
por: van der Wal, Bart C. H., et al.
Publicado: (2023)

RNA Splicing in Cancer and Targeted Therapies
por: Islam, Md Rafikul, et al.
Publicado: (2023)

Complementary and Alternative Therapies Targeting Inflammasomes for Human Diseases
por: Yi, Young-Su, et al.
Publicado: (2020)

Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018)

Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy
por: Arrouss, Issam, et al.
Publicado: (2013)

Dose Escalation Methods in Phase I Cancer Clinical Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2009)

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
por: Nemati, Fariba, et al.
Publicado: (2023)

Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the Clinic
por: Angelucci, Adriano
Publicado: (2019)

Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma
por: Glinkina, Kseniya, et al.
Publicado: (2022)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Targeting the protein kinases for anti-cancer therapy
por: Bang, Soo-Mee
Publicado: (2012)

Innovations in Personalized and Targeted Therapies for Breast Cancer
por: Harris, Eleanor E. R., et al.
Publicado: (2018)

Immunological targets for cancer therapy: new recognition
por: Shurin, Michael R
Publicado: (2018)

Editorial of the Special Issue “Targeted Therapies for Cancer”
por: Pastorino, Fabio, et al.
Publicado: (2022)

Is metabolism the magic bullet for targeted cancer therapy?
por: Trajkovic-Arsic, Marija, et al.
Publicado: (2023)

Kinase-targeted therapy in subsets of colorectal cancer
por: Gomez Barila, Patricia M., et al.
Publicado: (2023)

Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
por: Le Tourneau, Christophe, et al.
Publicado: (2012)

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
por: Tucker, Elizabeth R., et al.
Publicado: (2023)

Targeting the value of targeted therapy
por: Paggio, Joseph C. Del, et al.
Publicado: (2017)

Drug Development in Tissue-Agnostic Indications
por: du Rusquec, Pauline, et al.
Publicado: (2021)

MicroRNAs: Emerging Novel Targets of Cancer Therapies
por: Yang, Chengfeng, et al.
Publicado: (2015)

Targeting H(i)ck education for cancer therapy?
por: Ernst, Matthias, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5pvk762l9pbre6onsitnqigdep